Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Protection from injury of organs adjacent to a renal tumor during percutaneous cryoablation.

Yamagami T, Yoshimatsu R, Kajiwara K, Yamanishi T, Minamiguchi H, Karashima T, Inoue K.

Int J Urol. 2019 May 15. doi: 10.1111/iju.14013. [Epub ahead of print] Review.

PMID:
31094038
2.

Variations in the Efficiency of Albuterol Delivery and Intrapulmonary Effects With Differential Parameter Settings on Intrapulmonary Percussive Ventilation.

Karashima T, Mimura-Kimura Y, Miyakawa K, Nakamura A, Shimahara F, Kamei H, Mimura Y.

Respir Care. 2019 May;64(5):502-508. doi: 10.4187/respcare.06348. Epub 2019 Mar 19.

PMID:
30890628
3.

Time-Dependent Effects of Cryoablation for Renal Tumor on Overall and Split Renal Function.

Yoshimatsu R, Yamagami T, Nishimori M, Ogi K, Murata Y, Iwasa H, Kajiwara K, Yamanishi T, Minamiguchi H, Karashima T, Inoue K.

J Vasc Interv Radiol. 2019 Mar;30(3):460-465. doi: 10.1016/j.jvir.2018.10.017.

PMID:
30819494
4.

5-Aminolevulinic acid with ferrous iron improves early renal damage and hepatic steatosis in high fat diet-induced obese mice.

Kamiya A, Hara T, Tsuda M, Tsuru E, Kuroda Y, Ota U, Karashima T, Fukuhara H, Inoue K, Ishizuka M, Nakajima M, Tanaka T.

J Clin Biochem Nutr. 2019 Jan;64(1):59-65. doi: 10.3164/jcbn.18-35. Epub 2018 Oct 2.

5.

Bilateral Xp11.2 translocation renal cell carcinoma: a case report.

Karashima T, Kuno T, Kuroda N, Satake H, Fukata S, Chikazawa M, Kawada C, Yamasaki I, Shuin T, Hiroi M, Inoue K.

BMC Urol. 2018 Nov 20;18(1):106. doi: 10.1186/s12894-018-0419-3.

6.

Lysophospholipids Facilitate COPII Vesicle Formation.

Melero A, Chiaruttini N, Karashima T, Riezman I, Funato K, Barlowe C, Riezman H, Roux A.

Curr Biol. 2018 Jun 18;28(12):1950-1958.e6. doi: 10.1016/j.cub.2018.04.076. Epub 2018 Jun 7.

7.

An Advanced Well-differentiated Pancreatic Neuroendocrine Carcinoma (NET-G3) Associated with Von Hippel-Lindau Disease.

Miki M, Kawabe K, Igarashi H, Abe T, Ohishi Y, Hashimoto R, Karashima T, Yamasaki I, Inoue K, Ito T, Ogawa Y.

Intern Med. 2018 Jul 15;57(14):2007-2011. doi: 10.2169/internalmedicine.0416-17. Epub 2018 Feb 28.

8.

Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer.

Nakagawa M, Karashima T, Kamada M, Yoshida E, Yoshimura T, Nojima M, Inoue K, Shuin T, Seiki M, Koshikawa N.

Biomark Res. 2017 Oct 13;5:29. doi: 10.1186/s40364-017-0109-4. eCollection 2017.

9.

Therapy with transcutaneous administration of imiquimod combined with oral administration of sorafenib suppresses renal cell carcinoma growing in an orthotopic mouse model.

Karashima T, Udaka K, Niimura M, Suzuki K, Osakabe H, Shimamoto T, Fukata S, Inoue K, Kuroda N, Seiki M, Shuin T.

Oncol Lett. 2017 Jul;14(1):1162-1166. doi: 10.3892/ol.2017.6235. Epub 2017 May 24.

10.

Unique mouse monoclonal antibodies reactive with maturation-related epitopes on type VII collagen.

Hayakawa T, Hirako Y, Teye K, Tsuchisaka A, Koga H, Ishii N, Karashima T, Kaneda M, Oyu Y, Tateishi C, Sugawara K, Yonamine A, Shinkuma S, Shimizu H, Fukano H, Shimozato K, Nguyen NT, Marinkovich MP, Tsuruta D, Hashimoto T.

Exp Dermatol. 2017 Sep;26(9):811-819. doi: 10.1111/exd.13306. Epub 2017 Apr 20.

PMID:
28111846
11.

Frequency of reactive arthritis, uveitis, and conjunctivitis in Japanese patients with bladder cancer following intravesical BCG therapy: A 20-year, two-centre retrospective study.

Taniguchi Y, Nishikawa H, Karashima T, Yoshinaga Y, Fujimoto S, Terada Y.

Joint Bone Spine. 2017 Oct;84(5):637-638. doi: 10.1016/j.jbspin.2016.09.014. Epub 2016 Nov 4. No abstract available.

PMID:
27825571
12.

Summary of results of serological tests and diagnoses for 4774 cases of various autoimmune bullous diseases consulted to Kurume University.

Hashimoto T, Tsuruta D, Koga H, Fukuda S, Ohyama B, Komai A, Karashima T, Ohata C, Teye K, Ishii N.

Br J Dermatol. 2016 Nov;175(5):953-965. doi: 10.1111/bjd.14692. Epub 2016 Sep 11.

PMID:
27106498
13.

Effective induction of cytotoxic T cells recognizing an epitope peptide derived from hypoxia-inducible protein 2 (HIG2) in patients with metastatic renal cell carcinoma.

Obara W, Karashima T, Takeda K, Kato R, Kato Y, Kanehira M, Takata R, Inoue K, Katagiri T, Shuin T, Nakamura Y, Fujioka T.

Cancer Immunol Immunother. 2017 Jan;66(1):17-24. doi: 10.1007/s00262-016-1915-5. Epub 2016 Oct 18.

14.

Isolation of All CD44 Transcripts in Human Epidermis and Regulation of Their Expression by Various Agents.

Teye K, Numata S, Ishii N, Krol RP, Tsuchisaka A, Hamada T, Koga H, Karashima T, Ohata C, Tsuruta D, Saya H, Haftek M, Hashimoto T.

PLoS One. 2016 Aug 9;11(8):e0160952. doi: 10.1371/journal.pone.0160952. eCollection 2016.

15.

Functional study of TGM1 missense mutations in autosomal recessive congenital ichthyosis.

Numata S, Teye K, Karashima T, Matsuda M, Hamada T, Hashimoto T.

Exp Dermatol. 2016 Aug;25(8):657-9. doi: 10.1111/exd.13000. Epub 2016 Jun 15. No abstract available.

PMID:
26990434
16.

Chromophobe renal cell carcinoma, eosinophilic variant with papillary growth: a case report.

Karashima T, Kuroda N, Taguchi T, Matsumoto M, Hiroi M, Nao T, Fukata S, Inoue K, Shuin T.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):13590-5. eCollection 2015.

17.

Adrenal and thyroid metachronous metastases from renal cell carcinoma.

Taguchi T, Karashima T, Terada Y.

Endocrine. 2016 Jul;53(1):335-6. doi: 10.1007/s12020-015-0815-3. Epub 2015 Nov 26. No abstract available.

PMID:
26611247
18.

Urinary laminin-γ2 is a novel biomarker of non-muscle invasive urothelial carcinoma.

Kamada M, Koshikawa N, Minegishi T, Kawada C, Karashima T, Shuin T, Seiki M.

Cancer Sci. 2015 Dec;106(12):1730-7. doi: 10.1111/cas.12832. Epub 2015 Nov 6.

19.

Shikonin Promotes Skin Cell Proliferation and Inhibits Nuclear Factor-κB Translocation via Proteasome Inhibition In Vitro.

Yan Y, Furumura M, Gouya T, Iwanaga A, Teye K, Numata S, Karashima T, Li XG, Hashimoto T.

Chin Med J (Engl). 2015 Aug 20;128(16):2228-33. doi: 10.4103/0366-6999.162512.

20.

Sphingolipids regulate telomere clustering by affecting the transcription of genes involved in telomere homeostasis.

Ikeda A, Muneoka T, Murakami S, Hirota A, Yabuki Y, Karashima T, Nakazono K, Tsuruno M, Pichler H, Shirahige K, Kodama Y, Shimamoto T, Mizuta K, Funato K.

J Cell Sci. 2015 Jul 15;128(14):2454-67. doi: 10.1242/jcs.164160. Epub 2015 Jun 4.

21.

Combination with third-generation bisphosphonate (YM529) and interferon-alpha can inhibit the progression of established bone renal cell carcinoma.

Kurabayashi A, Inoue K, Fukuhara H, Karashima T, Fukata S, Kawada C, Shuin T, Furihata M.

Cancer Sci. 2015 Aug;106(8):1092-9. doi: 10.1111/cas.12711. Epub 2015 Jul 14.

22.

Review of renal cell carcinoma with rhabdoid features with focus on clinical and pathobiological aspects.

Kuroda N, Karashima T, Inoue K, Kasajima A, Ohe C, Kawakami F, Mikami S, Matsuura K, Moriyama M, Nagashima Y, Petersson F, Lopez JI, Cohen RJ, Michal M, Hes O.

Pol J Pathol. 2015 Mar;66(1):3-8. Review.

23.

Mutation study for 9 genes in 23 unrelated patients with autosomal recessive congenital ichthyosis in Japan and Malaysia.

Numata S, Teye K, Krol RP, Karashima T, Fukuda S, Matsuda M, Ishii N, Furumura M, Ohata C, Saminathan SD, Ariffin R, Pramono ZA, Leong KF, Hamada T, Hashimoto T.

J Dermatol Sci. 2015 Apr;78(1):82-5. doi: 10.1016/j.jdermsci.2015.02.006. Epub 2015 Feb 19. No abstract available. Erratum in: J Dermatol Sci. 2015 Aug;79(2):179-80.

PMID:
25766764
24.

IgG4-related disease of the paratestis in a patient with Wells syndrome: a case report.

Karashima T, Taniguchi Y, Shimamoto T, Nao T, Nishikawa H, Fukata S, Kamada M, Inoue K, Oko K, Nakajima H, Sano S, Matsumoto M, Kuroda N, Kamei Y, Shuin T.

Diagn Pathol. 2014 Dec 9;9:225. doi: 10.1186/s13000-014-0225-5. Review.

25.

Various peroxisome proliferator-activated receptor (PPAR)-γ agonists differently induce differentiation of cultured human keratinocytes.

Yan Y, Furumura M, Numata S, Teye K, Karashima T, Ohyama B, Tanida N, Hashimoto T.

Exp Dermatol. 2015 Jan;24(1):62-5. doi: 10.1111/exd.12571.

PMID:
25346431
26.

IgG4-related renal disease: clinical and pathological characteristics.

Kuroda N, Nao T, Fukuhara H, Karashima T, Inoue K, Taniguchi Y, Takeuchi M, Zen Y, Sato Y, Notohara K, Yoshino T.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):6379-85. eCollection 2014. Review.

27.

[Clinical study on patients with renal-cell carcinoma accompanied with Von Hippel-Lindau disease treated with radiofrequency ablation].

Nao T, Shimamoto T, Karashima T, Kamei M, Fukuhara H, Fukata S, Satake H, Ashida S, Yamasaki I, Kamata M, Inoue K, Yamanishi T, Ogawa Y, Ito S, Shuin T.

Hinyokika Kiyo. 2014 Sep;60(9):415-20. Japanese.

28.

Frequent office visits for injections may reduce adalimumab survival rate in patients with psoriasis.

Ohata C, Shintani T, Arakawa M, Yoshimura K, Ohyama B, Ishii N, Ono F, Hamada T, Karashima T, Furumura M.

J Dermatolog Treat. 2015;26(4):312-3. doi: 10.3109/09546634.2014.962470. Epub 2014 Sep 26. No abstract available.

PMID:
25219402
29.

Oesophageal involvement in epidermolysis bullosa acquisita.

Ishii N, Furumura M, Hamada T, Mori O, Ohzono A, Ueda A, Karashima T, Nakama T, Tsuruta D, Takedatsu H, Fujita H, Hashimoto T.

Br J Dermatol. 2015 Jan;172(1):288-90. doi: 10.1111/bjd.13224. Epub 2014 Nov 19. No abstract available.

PMID:
24975454
30.

Clinical characteristics of Japanese patients with reactive arthritis following intravesical BCG therapy for bladder cancer.

Taniguchi Y, Karashima T, Yoshinaga Y, Shuin T, Fujimoto S, Terada Y.

Mod Rheumatol. 2015 Jan;25(1):161-3. doi: 10.3109/14397595.2014.926853. Epub 2014 Jun 20. No abstract available.

PMID:
24947826
31.

B-cell activating factor detected on both naïve and memory B cells in bullous pemphigoid.

Qian H, Kusuhara M, Li X, Tsuruta D, Tsuchisaka A, Ishii N, Koga H, Hayakawa T, Ohara K, Karashima T, Ohyama B, Ohata C, Furumura M, Hashimoto T.

Exp Dermatol. 2014 Aug;23(8):596-605. doi: 10.1111/exd.12421. Epub 2014 Jul 16.

PMID:
24758362
32.

Distinct protein expression and activity of transglutaminases found in different epidermal tumors.

Karashima T, Furumura M, Ishii N, Ohyama B, Saruta H, Natsuaki Y, Nakama T, Ohata C, Tsuruta D, Hitomi K, Hashimoto T.

Exp Dermatol. 2014 Jun;23(6):433-5. doi: 10.1111/exd.12418.

PMID:
24750515
33.

Clinical and immunological profiles in 17 Japanese patients with drug-induced pemphigus studied at Kurume University.

Yoshimura K, Ishii N, Hamada T, Abe T, Ono F, Hashikawa K, Fukuda S, Ohyama B, Koga H, Sogame R, Teye K, Ochiai T, Nakajima H, Nakajima K, Iijima S, Kanzaki M, Kojima K, Nagatani T, Fujimoto W, Karashima T, Nakama T, Ohata C, Furumura M, Tsuruta D, Hashimoto T.

Br J Dermatol. 2014 Sep;171(3):544-53. doi: 10.1111/bjd.12925. Epub 2014 Aug 27.

PMID:
24588203
34.

Novel combination therapy with imiquimod and sorafenib for renal cell carcinoma.

Karashima T, Komatsu T, Niimura M, Kawada C, Kamada M, Inoue K, Udaka K, Kuroda N, Shuin T.

Int J Urol. 2014 Jul;21(7):702-6. doi: 10.1111/iju.12401. Epub 2014 Feb 27.

35.

5-Aminolevulinic acid protects against cisplatin-induced nephrotoxicity without compromising the anticancer efficiency of cisplatin in rats in vitro and in vivo.

Terada Y, Inoue K, Matsumoto T, Ishihara M, Hamada K, Shimamura Y, Ogata K, Inoue K, Taniguchi Y, Horino T, Karashima T, Tamura K, Fukuhara H, Fujimoto S, Tsuda M, Shuin T.

PLoS One. 2013 Dec 6;8(12):e80850. doi: 10.1371/journal.pone.0080850. eCollection 2013.

36.

Morphological changes of the hair roots in alopecia areata: a scanning electron microscopic study.

Karashima T, Tsuruta D, Hamada T, Ishii N, Ono F, Ueda A, Abe T, Nakama T, Dainichi T, Hashimoto T.

J Dermatol. 2013 Dec;40(12):1045-8. doi: 10.1111/1346-8138.12350. Epub 2013 Dec 4.

PMID:
24304217
37.

Pathological risk factors in upper urinary tract cancer.

Shimamoto T, Inoue K, Kamata M, Kuno T, Karashima T, Shuin T.

Asia Pac J Clin Oncol. 2016 Mar;12(1):e179-88. doi: 10.1111/ajco.12155. Epub 2013 Dec 2.

PMID:
24289213
38.

[First experiences of laparoscopic radical cystectomy].

Karashima T, Inoue K, Fukata S, Ashida S, Shimamoto T, Fukuhara H, Anchi T, Kamei M, Tamura K, Yamasaki I, Kamada M, Satake H, Shuin T.

Nihon Hinyokika Gakkai Zasshi. 2013 Sep;104(5):644-50. Japanese.

PMID:
24187851
39.

Complete maternal isodisomy of chromosome 5 in a Japanese patient with Netherton syndrome.

Numata S, Hamada T, Teye K, Matsuda M, Ishii N, Karashima T, Kabashima K, Furumura M, Ohata C, Hashimoto T.

J Invest Dermatol. 2014 Mar;134(3):849-852. doi: 10.1038/jid.2013.398. Epub 2013 Sep 16. No abstract available.

40.

An attempt to develop mouse model for anti-laminin γ1 pemphigoid.

Koga H, Ishii N, Dainichi T, Tsuruta D, Hamada T, Ohata C, Karashima T, Furumura M, Hashimoto T.

J Dermatol Sci. 2013 May;70(2):108-15. doi: 10.1016/j.jdermsci.2013.01.001. Epub 2013 Jan 24.

PMID:
23410740
41.

Anti-α-2-macroglobulin-like-1 autoantibodies are detected frequently and may be pathogenic in paraneoplastic pemphigus.

Numata S, Teye K, Tsuruta D, Sogame R, Ishii N, Koga H, Natsuaki Y, Tsuchisaka A, Hamada T, Karashima T, Nakama T, Furumura M, Ohata C, Kawakami T, Schepens I, Borradori L, Hashimoto T.

J Invest Dermatol. 2013 Jul;133(7):1785-93. doi: 10.1038/jid.2013.65. Epub 2013 Feb 13.

42.

Nodular morphea (NM): report of a case of concurrent NM and morphea profunda associated with limited type systemic sclerosis, and overview and definition for NM.

Ohata C, Yasunaga M, Tsuruta D, Ishii N, Hamada T, Dainichi T, Karashima T, Nakama T, Hashimoto T.

Eur J Dermatol. 2013 Jan-Feb;23(1):87-93. doi: 10.1684/ejd.2012.1893. Review.

PMID:
23400240
43.

Expression of angiogenesis-related gene profiles and development of resistance to tyrosine-kinase inhibitor in advanced renal cell carcinoma: characterization of sorafenib-resistant cells derived from a cutaneous metastasis.

Karashima T, Fukuhara H, Tamura K, Ashida S, Kamada M, Inoue K, Taguchi T, Kuroda N, Shuin T.

Int J Urol. 2013 Sep;20(9):923-30. doi: 10.1111/iju.12084. Epub 2013 Feb 4.

44.

Perturbation of sphingolipid metabolism induces endoplasmic reticulum stress-mediated mitochondrial apoptosis in budding yeast.

Kajiwara K, Muneoka T, Watanabe Y, Karashima T, Kitagaki H, Funato K.

Mol Microbiol. 2012 Dec;86(5):1246-61. doi: 10.1111/mmi.12056. Epub 2012 Oct 17.

45.

How do keratinizing disorders and blistering disorders overlap?

Hamada T, Tsuruta D, Fukuda S, Ishii N, Teye K, Numata S, Dainichi T, Karashima T, Ohata C, Furumura M, Hashimoto T.

Exp Dermatol. 2013 Feb;22(2):83-7. doi: 10.1111/exd.12021. Epub 2012 Oct 8. Review.

46.

Mizoribine treatment for antihistamine-resistant chronic autoimmune urticaria.

Hashimoto T, Kawakami T, Ishii N, Ishii K, Karashima T, Nakama T, Tsuruta D, Dainichi T, Hide M, Hamada T.

Dermatol Ther. 2012 Jul-Aug;25(4):379-81. doi: 10.1111/j.1529-8019.2012.01468.x.

PMID:
22950565
47.

Low-dose cyclosporin improves the health-related quality of life in Japanese psoriasis patients dissatisfied with topical corticosteroid monotherapy.

Hashimoto T, Kawakami T, Tsuruta D, Hamada T, Natsuaki Y, Fukuda S, Koga H, Sogame R, Ohyama B, Ono F, Karashima T, Nakama T, Dainichi T, Ishii N, Yasumoto S.

Australas J Dermatol. 2012 Aug;53(3):202-6. doi: 10.1111/j.1440-0960.2011.00870.x. Epub 2012 Feb 23.

PMID:
22881466
48.

Oral zinc therapy for zinc deficiency-related telogen effluvium.

Karashima T, Tsuruta D, Hamada T, Ono F, Ishii N, Abe T, Ohyama B, Nakama T, Dainichi T, Hashimoto T.

Dermatol Ther. 2012 Mar-Apr;25(2):210-3. doi: 10.1111/j.1529-8019.2012.01443.x.

PMID:
22741940
49.

SNRPE is involved in cell proliferation and progression of high-grade prostate cancer through the regulation of androgen receptor expression.

Anchi T, Tamura K, Furihata M, Satake H, Sakoda H, Kawada C, Kamei M, Shimamoto T, Fukuhara H, Fukata S, Ashida S, Karashima T, Yamasaki I, Yasuda M, Kamada M, Inoue K, Shuin T.

Oncol Lett. 2012 Feb;3(2):264-268. Epub 2011 Dec 1.

50.

Decline of disease activity and autoantibodies to desmoglein 3 and envoplakin by oral prednisolone in paraneoplastic pemphigus with benign thymoma.

Ishii N, Hamada T, Koga H, Sogame R, Ohyama B, Fukuda S, Natsuaki Y, Dainichi T, Karashima T, Nakama T, Tsuruta D, Hashimoto T.

Eur J Dermatol. 2012 Jul-Aug;22(4):547-9. doi: 10.1684/ejd.2012.1742. No abstract available.

PMID:
22548836

Supplemental Content

Loading ...
Support Center